Patent Assignment
Reel/Frame 061406/0499
Merger
Recorded: 2022-09-09
Pages: 9
Assignor
PROTIVA BIOTHERAPEUTICS, INC.
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Methods of Delivering Oligonucleotides to Immune Cells
Application:
17/244,445 →
Publication:
US 2022/0079970
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 2022
From: NOVOBRANTSEVA, TATIANA; AKINC, AKIN; SUGO, TSUKASA
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 059983/0009 →
Assignment of Assignor's Interest
Aug 9, 2022
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 060759/0665 →
Change of Name
Aug 26, 2022
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 060908/0852 →